Stay updated on Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.

Latest updates to the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page
- Check6 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, indicating a routine change to the ClinicalTrials.gov site version rather than any study-specific information.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision: v3.5.2 replaces the previous v3.5.0.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0, indicating a minor update to the page template and metadata.SummaryDifference0.0%

- Check49 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3; there are no changes to study content or functionality.SummaryDifference0.0%

- Check77 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior notice for Revision: v3.4.1; these are administrative updates to the site.SummaryDifference0.3%

- Check85 days agoChange DetectedAdded a site-wide notice regarding a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.